Investor Presentaiton

sanofi Ambition to match our Standard of Care in influenza with Sanofi's next-generation mRNA vaccine Machine learning Utilize advanced computational techniques to optimize strain selection Y Antigen composition Focus on neuraminidase to improve vaccine effectiveness 51 Vaccines Investor Event Protection Beyond Flu is the centerpiece of clinical efforts

View entire presentation